XXXX yields 5.19% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 10
Combined, XXXX + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of XXXX + JNJ for your $10,000?
XXXX is a leveraged ETN that aims to provide amplified exposure to the US large-cap sector. Its objective is to quadruple the daily performance of the S&P 500 total return index, which encompasses stock prices and dividends from the 500 largest US equity market companies. Its important to note that investors take on the credit risk of BMO in exchange for the certainty of pure tracking. Unlike traditional investment products, XXXX does not guarantee any return of principal at redemption or maturity. Instead, it strives to generate a return that is four times the daily performance of the underlying index. The leveraged characteristic makes XXXX best suited for short-term trading strategies rather than long-term investments. Its crucial to consider that the effects of daily compounding can result in deviations of long-term returns from the performance of the index.
Full XXXX Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.